Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.2205
-0.0094 (-4.09%)
At close: Feb 25, 2026, 4:00 PM EST
0.2201
-0.0004 (-0.18%)
After-hours: Feb 25, 2026, 7:52 PM EST
RVPH Market Cap
RVPH has a market cap or net worth of $25.77 million as of February 25, 2026. Its market cap has decreased by -73.41% in one year.
Market Cap
25.77M
Enterprise Value
12.58M
1-Year Change
-73.41%
Ranking
Category
Stock Price
$0.22
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $25.77M, an increase of 2.20%. That is a compound annual growth rate of 0.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 26.86M | -17.60% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 28.74M |
| AN2 Therapeutics | 28.50M |
| NeuroSense Therapeutics | 27.35M |
| BriaCell Therapeutics | 27.19M |
| Marker Therapeutics | 27.18M |
| IGC Pharma | 26.72M |
| Klotho Neurosciences | 26.38M |
| Boundless Bio | 26.19M |